ReviewCancers2021

The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers.

Narasimha M Beeraka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.